Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.

Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.

Webinar presenter Jeffrey Gregg, MD, University of Nevada

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.

Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

Marketplace

Biofluid sample prep kits, 9/13:103

Qiagen announced a partnership with Exosome Diagnostics to develop and commercialize high-performance biofluid sample preparation kits for the processing of nucleic acids from exosomes. Combining Exosome Diagnostics’ platform technology approach with select Qiagen consumables and automation platforms has the potential to allow researchers, drug developers, and medical professionals to take repeated, real-time genetic “snapshots” of disease from patients’ blood, urine, or cerebrospinal fluid without the need for tissue biopsy. Qiagen’s exosome technology-driven kits will offer the ability to work with

BacTx rapid test for bacteria in platelets, 9/13:103

Immunetics has received FDA clearance for its BacTx rapid test for bacteria in apheresis platelets. The BacTx system is a colorimetric assay that can detect aerobic, anaerobic, gram-negative, and gram-positive bacteria in a single test. The BacTx assay uses a patented, specific, universal bacterial detection reagent that has been shown to detect wild and cultured bacterial strains. BacTx is intended for use as a point-of-issue test performed at the transfusion site on the day of issue. The BacTx assay can

Water purification system, 9/13:103

ELGA Process Water introduces the Medica Pro electrodeionization (EDI) water purification system. The system consistently produces high-purity water at economical running costs for immunochemistry and general chemistry automated clinical analyzers. ELGA’s Pulse technology combined with extended intervals between sanitization reduces maintenance time.

Anti-PIN5 cocktail, 9/13:103

Diagnostic BioSystems’ anti-PIN5 cocktail helps distinguish prostate cancer from benign conditions that mimick cancer. The cocktail works through the combined detection of p504S, p40, and high molecular-weight cytokeratin markers. The markers are particularly relevant in helping to diagnose prostatic intraepithelial neoplasia. The markers also offer utility in difficult cases where tissue may be limited.

Sysmex renews deal to distribute EasyCell, 9/13

Sysmex America has renewed its agreement to distribute Medica’s EasyCell assistant for digital cell image analysis in hematology laboratories. EasyCell uses optical pattern recognition software to automatically locate white cells on a blood smear. It digitally stores, preclassifies, and presents images for review, grouped by cell type, on an LCD display.

Immunoassay specialty controls, 9/13:102

Randox Laboratories has received FDA approval for its Acusera immunoassay specialty 1 control for use in U.S. laboratories. The multi-analyte, lyophilized control contains I-25-(OH)2-vitamin D, 25-OH-vitamin D, C peptide, insulin, insulin-like growth factor-1, procalcitonin, parathyroid hormone, anti-thyroglobulin, and anti-thyroperoxidase.

Oncotype DX prostate cancer test, 9/13

Genomic Health made its Oncotype DX prostate cancer test available recently after a presentation of a positive clinical validation study by the University of California, San Francisco, at this year’s American Urological Association annual meeting.

Phlebotomy ‘boot camp’, 9/13

The Center for Phlebotomy Education is conducting a three-day seminar for those who train or manage phlebotomists. It will take place Nov. 6–8 at the Brown Hotel in Louisville, Ky. The staff of the Center for Phlebotomy Education will conduct the sessions. They are program administrator Catherine Ernst, RN, PBT(ASCP); program coordinator Lisa Steinam, PBT(ASCP); and executive director Dennis J. Ernst, MT(ASCP).

Under counter refrigerators and freezers, 9/13

Helmer Scientific’s i.Series and Horizon Series under counter refrigerators and freezers are available in ADA-compatible models. These models are designed to fit under 34-inch ADA-compliant counters and offer chamber temperature uniformity with quick recovery, bacteria-resistant powder coating, and a self-closing door with magnetic latch.

MARKETPLACE

TRENDING